Article Text

other Versions

Authors’ response: virus–host interactions in HBV-related hepatocellular carcinoma: more to be revealed?
  1. Qian Cao1,2,3,4,
  2. Sandrine Imbeaud1,2,3,4,
  3. Shalini Datta1,2,3,4,
  4. Jessica Zucman-Rossi1,2,3,4,5
  1. 1Inserm, UMR-1162, Génomique fonctionnelle des tumeurs solides, IUH, Paris, France
  2. 2Faculté de Médecine, Université Paris Descartes, Labex Immuno-oncology, Sorbonne Paris Cité, Paris, France
  3. 3Université Paris 13, Sorbonne Paris Cité, UFR SMBH, Bobigny, France
  4. 4Université Paris Diderot, Paris, France
  5. 5Assistance Publique-Hôpitaux de Paris, Hopital Europeen Georges Pompidou, Paris, France
  1. Correspondence to Professor Jessica Zucman-Rossi, Inserm U1162, Génomique fonctionnelle des tumeurs solides, 27 rue Juliette Dodu, Paris 75010, France; jessica.zucman-rossi{at}

Statistics from

We acknowledge Cao et al1 for being interested in our recent study on molecular features of hepatitis B related hepatocellular carcinoma (HBV-related HCC).2 As they suggested, we searched for the HBx-LINE1 chimerical transcript recently identified in a Chinese population of HBV-related HCC by Lau et al3 in our series of HCC treated in France.2 To this aim, we have selected and analysed 50 HBV-related HCC tumours which were included in our last report.2 Total RNAs were extracted using Trizol (Invitrogen) from frozen tissues and converted into …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles